Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Skin Cancer Channel

Explore the latest updates, including expert interviews and features

The Skin Cancer Channel on VJOncology is supported by Replimune. Supporters have no influence over the production of the content.

Latest Videos Conferences Subtypes Topics Podcasts

Welcome to the Skin Cancer Channel!

VJOncology brings you the latest developments in the field of skin cancer, keeping you up-to-date with the most exciting developments with video interviews, podcasts, and roundtable discussions, and more.

Reporting from key international congresses, catch up on the key advances in skin cancer, including the use of novel treatment approaches, key trial updates as well as expert opinions in clinical approaches.

Conferences

AACR 2024
ESMO 2023
ASCO 2023
AACR 2023
ESMO 2022
ASCO 2022
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
2:12
Novel immunotherapeutic approaches to treat patients with melanoma
Christoffer Gebhardt • 9 Apr 2024
1:22
INTerpath-001: individualized neoantigen vaccines with pembrolizumab in melanoma
Christoffer Gebhardt • 9 Apr 2024
2:15
Reducing the need for sentinel node biopsies in cutaneous melanoma
Christoffer Gebhardt • 9 Apr 2024
View All Videos
0:36
Total tumor volume is predictive of patient response to immunotherapy
Marco Donia • 23 Nov 2023
0:43
Multicolor immunofluorescence to predict melanoma immunotherapy responses
Marco Donia • 22 Oct 2023
0:57
Multiparametric MRI for predicting immunotherapy response in melanomas
Marco Donia • 23 Oct 2023
1:05
Updates in melanoma at ESMO 2023
Marco Donia • 23 Oct 2023
View All Videos
1:40
MATISSE: nivolumab in cutaneous squamous cell carcinoma
Charlotte Zuur • 4 Jun 2023
1:27
Validating MIA & MSKCC predictive tool for melanoma sentinel node status
Roger Olofsson Bagge • 4 Jun 2023
1:22
The personalization of neoadjuvant immunotherapy in stage III melanoma
Minke Lucas • 4 Jun 2023
0:40
Gamma signature guidance in optimizing neoadjuvant immunotherapy for resectable melanoma
Minke Lucas • 4 Jun 2023
View All Videos
1:26
The future of personalized, neoantigen cancer vaccines
Jeffrey Weber • 20 Apr 2023
4:10
A personalized mRNA vaccine with pembrolizumab in melanoma
Jeffrey Weber • 20 Apr 2023
2:20
The potential impact of lifileucel on the treatment landscape of melanoma
Omid Hamid • 17 Apr 2023
1:17
Intratumoral MEDI1191 encoding IL-12 in solid tumors
Omid Hamid • 18 Apr 2023
View All Videos
0:35
Potential advantages of neoadjuvant immunotherapy for melanoma
Sapna Patel • 12 Sep 2022
0:27
SWOG S1801: Escalation vs. deescalation of immunotherapy for melanoma
Sapna Patel • 12 Sep 2022
1:40
SWOG S1801: Benefits of neoadjuvant immunotherapy for patients with resectable melanoma
Sapna Patel • 12 Sep 2022
1:28
Highlights from ESMO 2022 in melanoma
Omid Hamid • 12 Sep 2022
View All Videos
2:26
Overcoming barriers in treating melanoma brain metastases
Bently Doonan • 7 Jun 2022
3:51
Evaluating the mechanism of action of emavusertib
Bently Doonan • 7 Jun 2022
0:39
Pembrolizumab, emavusterib + radiosurgery: a novel trimodal therapy for metastatic melanoma
Bently Doonan • 14 Jun 2022
1:20
Resistance to immune checkpoint blockade in patients with cSCC
Paolo Bossi • 5 Jun 2022
View All Videos

Topics

Trial Updates
Immuno-Oncology
Clinical Practice
Surgery
Molecular Profiling
1:22
INTerpath-001: individualized neoantigen vaccines with pembrolizumab in melanoma
Christoffer Gebhardt • 9 Apr 2024
3:45
PERIO: novel SD-101 treatment of uveal melanoma
Diwakar Davar • 2 Nov 2023
0:43
Multicolor immunofluorescence to predict melanoma immunotherapy responses
Marco Donia • 22 Oct 2023
1:29
Future clinical trials assessing DR-18 in renal cell carcinoma and melanoma
David Schoenfeld • 14 Nov 2023
View All Videos
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
2:12
Novel immunotherapeutic approaches to treat patients with melanoma
Christoffer Gebhardt • 9 Apr 2024
1:22
INTerpath-001: individualized neoantigen vaccines with pembrolizumab in melanoma
Christoffer Gebhardt • 9 Apr 2024
1:18
Elucidating ICI resistance in melanoma with ctDNA and tumor profiling
Christoffer Gebhardt • 9 Apr 2024
View All Videos
0:36
Total tumor volume is predictive of patient response to immunotherapy
Marco Donia • 23 Nov 2023
1:27
Validating MIA & MSKCC predictive tool for melanoma sentinel node status
Roger Olofsson Bagge • 4 Jun 2023
1:22
The personalization of neoadjuvant immunotherapy in stage III melanoma
Minke Lucas • 4 Jun 2023
1:55
Impact of emotional distress on pathologic response in high-risk stage III melanoma
Irene Reijers • 4 Jun 2023
View All Videos
1:40
MATISSE: nivolumab in cutaneous squamous cell carcinoma
Charlotte Zuur • 4 Jun 2023
1:27
Validating MIA & MSKCC predictive tool for melanoma sentinel node status
Roger Olofsson Bagge • 4 Jun 2023
3:22
Incidence, landscape and survival outcome of de novo malignancy after double lung transplantation
Young Kwang Chae • 3 Jun 2023
1:30
Omission of adjuvant therapy and TLND in melanoma: insights from OpACIN-neo, PRADO, and NADINA
Irene Reijers • 4 Jun 2023
View All Videos
2:15
Reducing the need for sentinel node biopsies in cutaneous melanoma
Christoffer Gebhardt • 9 Apr 2024
1:20
Can ctDNA guide the treatment decision making process in melanoma?
Christoffer Gebhardt • 9 Apr 2024
1:18
Elucidating ICI resistance in melanoma with ctDNA and tumor profiling
Christoffer Gebhardt • 9 Apr 2024
1:48
Ultra-sensitive ctDNA monitoring predicts ICI response in melanoma
Christoffer Gebhardt • 9 Apr 2024
View All Videos
The Skin Cancer Channel on VJOncology is supported by Replimune. Supporters have no influence over the production of the content.
If you are interested in becoming a supporter of The Skin Cancer Channel, please contact us .
The content of VJOncology is intended for healthcare professionals